The SBIR program democratizes funding for emerging companies, providing critical financial resources to regions of the country that may not have access to the venture capital of the major metropolitan areas.
The VEGA series swept source OCT imaging systems have proven to be an excellent tool for a multitude of imaging applications. With this system series update, we aimed to increase the performance and ease of use for customers...The OCT applications team is available to assist with sample test runs and would be pleased to discuss how our OCT systems can be adapted to meet your needs.
It’s an interesting time in this market...Level 4 and 5 autonomy needs a level of performance, range, resolution, frame rate, and immunity that legacy ToF sensors just can’t deliver. Couple that to cost goals that can only be met with a true all-semiconductor solution and you see the challenge. We have the huge advantage that we’ve been designing and manufacturing the core technology in this FMCW LiDAR sensor for more than 10 years.
The initiation of our first U.S. based home OCT clinical trial is an important step towards bringing this leading-edge technology to eAMD patients, their caregivers, and the eye care community...Our collaboration with Wasatch Photonics will continue to be instrumental to our organization as the U.S. Food and Drug Administration (FDA) recently granted our Home Optical Coherence Tomography (OCT) System with ‘Breakthrough Device Designation’, a program designed to expedite patient access to novel technologies.
Our tests verified that a greatly reduced amount of experimental data can be used to reconstruct reasonable 3-D OCT images...After we perform enough experiments to demonstrate that our probe and imaging method are useful for observing malignant features, our technique will be ready for clinical trials...This work is just one example of applying computational techniques to imaging applications...We expect that similar approaches may be helpful for improving the experiment designs and data acquisition for many imaging modalities.
Our goal with this work is to help develop a faster, more efficient and less invasive diagnostic and treatment pathway for melanoma. Patients with advanced disease should get aggressive treatment as quickly as possible; also those with early-stage melanomas should not have to undergo expensive invasive Sentinel Lymph Node Biopsy operations if their melanoma is reliably confirmed as very low-risk. We believe Dynamic OCT imaging could help with these goals and the results of this study are very encouraging. The next stage of our work is to analyse the link between vessel shapes and the actual degree of metastasis of the melanomas in a larger cohort, and not just the Breslow depth.
When the heart develops, it becomes stiffer as required for ability to contract and pump blood...So the question is - does it become stiff because it's contracting, or is it stiff to begin with because it is genetically predefined?
One out of every 100 babies in the United States has a congenital heart defect leading to death...Understanding biomechanical regulation of heart development is highly important for better management of congenital heart defects.
The clearance of the IRIS product marks the successful culmination of a multi-year development effort within our organization, and with the Food and Drug Administration...This product is something we at NinePoint, and our customers, are very excited to bring to market. We pride ourselves in customer responsiveness and innovation, key inputs to this new product. We are eager to roll this out in a controlled-market release in the coming months prior to making the technology more broadly available.
